Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project
Open Access
- 17 November 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 124 (5), 1009-1017
- https://doi.org/10.1038/s41416-020-01152-5
Abstract
Background The Sloane audit compares screen-detected ductal carcinoma in situ (DCIS) pathology with subsequent management and outcomes. Methods This was a national, prospective cohort study of DCIS diagnosed during 2003–2012. Results Among 11,337 patients, 7204 (64%) had high-grade DCIS. Over time, the proportion of high-grade disease increased (from 60 to 65%), low-grade DCIS decreased (from 10 to 6%) and mean size increased (from 21.4 to 24.1 mm). Mastectomy was more common for high-grade (36%) than for low-grade DCIS (15%). Few (6%) patients treated with breast-conserving surgery (BCS) had a surgical margin n = 413), median time 62 months, followed by DCIS (n = 225), at median 37 months. Radiotherapy (RT) was most protective against recurrence for high-grade DCIS (3.2% for high-grade DCIS with RT compared to 6.9% without, compared with 2.3 and 3.0%, respectively, for low/intermediate-grade DCIS). Ipsilateral DCIS events lessened after 5 years, while the risk of ipsilateral invasive cancer remained consistent to beyond 10 years. Conclusion DCIS pathology informs patient management and highlights the need for prolonged follow-up of screen-detected DCIS.Keywords
Funding Information
- Cancer Research UK and by KWF Kankerbestrijding
This publication has 34 references indexed in Scilit:
- Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancerWorld Journal of Surgical Oncology, 2012
- The low nuclear grade breast neoplasia familyDiagnostic Histopathology, 2012
- HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situBritish Journal of Cancer, 2012
- Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trialThe Lancet Oncology, 2011
- A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trialBritish Journal of Cancer, 2010
- Post-operative radiotherapy for ductal carcinoma in situ of the breast – A systematic review of the randomised trialsThe Breast, 2009
- Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer EvolutionClinical Cancer Research, 2008
- Are microinvasion and micrometastasis in breast cancer mountains or molehills?The American Journal of Surgery, 2000
- Cytological and architectural heterogeneity in ductal carcinoma in situ of the breast.Journal of Clinical Pathology, 1997
- Extent, distribution, and mammographic/ histological correlations of breast ductal carcinoma in situThe Lancet, 1990